GlobeNewswire Inc | Aug 4, 2020 07:00AM EDT

August 04, 2020

MOUNTAIN VIEW, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced thatFred Schwarzer, Chief Executive Officer, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 11 at 1:45 p.m. ET.

A live webcast of the presentation will be available on the Events and Presentations page in the Investors section of the Companys website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Companys website for 90 days following the presentation.

About IGM Biosciences, Inc.Headquartered inMountain View, California,IGM Biosciencesis a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010,IGM Bioscienceshas worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts,IGM Bioscienceshas created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners David Pitts212-600-1902igmbio@argotpartners.com